Visit the MPX Bioceutical Corporation Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
MPX Reports Q2 Fiscal 2018 Results
Improving Gross Margins and Execution of Expansion Strategy
TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) — (CSE: MPX) (OTCQB:MPXEF)
MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE:MPX) (OTC:MPXEF) reports financial results for its second quarter of fiscal 2018, ended September 30, 2017.